Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Startups Strut on Stage at UNC Innovation Showcase 04/10/15 Raleigh Durham
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
Edge Brings in VC Backers, Gets $72.5M For Head Injury Drug 04/09/15 New York
Alzheon Gets $10M to Take Castoff Alzheimer’s Drug Into Pivotal Test 04/08/15 Boston
Juno, Novartis End CAR-T Patent Fight, With Juno A Little Richer 04/06/15 Seattle
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Doudna’s Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech 04/02/15 San Francisco
ZappRx Nabs $5.6M, Inks Zafgen Deal to E-Prescribe Obesity Meds 04/02/15 Boston
Days After $22M Raise, Gelesis Files for IPO 04/01/15 Boston
Equity Crowdfunding Backers Clash Over Fundraising Limits in States 04/01/15 National
Garabedian’s Rocky Road at Sarepta Ends With Abrupt Resignation 04/01/15 Boston
Xconomy Boston’s Top Stories of Q1 2015: Editor’s Picks 04/01/15 Boston
Fresh Off Boston Move, CoLucid Plots IPO For Migraine Drug Push 03/31/15 Raleigh Durham
Spruce Nabs $15M Series A to Connect Dermatologists and Patients 03/31/15 San Francisco
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
From Iceland to White House, Precision Medicine’s Promises & Hurdles 03/31/15 National
Arch, Flagship to Anchor NYCEDC’s $150M NY Biotech Fund 03/30/15 New York
In New Gene-Editing World, Doudna Applies Both Brake and Gas Pedal 03/27/15 San Francisco
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
As Pharma Collaborations Gain Importance, GSK Opens Second Outpost 03/27/15 San Diego
What’s Hot in Boston Biotech? Here’s the Agenda 03/26/15 Boston
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill 03/26/15 Boston
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date 03/26/15 Boston
Semma Secures $44M to Develop Diabetes Stem Cell Therapy 03/24/15 Boston
Alexion Deal in Hand, Blueprint Readies IPO Pitch 03/23/15 Boston
ImmunoGen Surges on $440M Takeda Deal For “Smart Bomb” Cancer Drugs 03/23/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline 03/20/15 Boston
Page 2 of 94 « previous page · next page »